Recent incarceration and use of a supervised injection facility in Vancouver, Canada

Addiction Research and Theory

Volumn 17, Issue 5, 2009, Pages 538-545

  Milloy, M J ^a   Wood, E ^a,b   Tyndall, M ^a,b   Lai, C ^a   Montaner, J ^a,b   Kerr, T ^a,c  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NONE   (Canada)

Author keywords

GEE; Incarceration; injection drug users; supervised injection facility

Indexed keywords

EID: 80052419346     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.1080/16066350802023065     Document Type: Article

References (51)

1. Adamson SJ, Sellman JD. 1998. The pattern of intravenous drug use and associated criminal activity in patients on a methadone treatment waiting list. Drug and Alcohol Review 17(2):159-166.
2. Beyrer C, Jittiwutikarn J, Teokul W, Razak MH, Suriyanon V, Srirak N, Vongchuk T, Tovanabutra S, Sripaipan T, Celentano DD. 2003. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS and Behavior 7(2):153-161. (Pubitemid 36781510)
3. Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, Koepsell TD. 2007. Release from prison-a high risk of death for former inmates. N Engl J Med 356(2):157-165. (Pubitemid 46089676)
4. Blumstein A, Rivara FP, Rosenfeld R. 2000. The rise and decline of homicide-and why. Annual Review of Public Health 21:505-541.
5. Bourgois P, Martinez A, Kral A, Edlin BR, Schonberg J, Ciccarone D. 2006. Reinterpreting ethnic patterns among white and African American men who inject heroin: A social science of medicine approach. PLoS Med 3(10):e452.
6. Bretteville-Jensen AL, Sutton M. 1996. The income-generating behaviour of injecting drug-users in Oslo. Addiction 91(1):63-79. (Pubitemid 26026811)
7. Broadhead RS, Kerr TH, Grund JPC, Altice FL. 2002. Safer Injection Facilities in North America: Their Place in Public Policy and Health Initiatives. Journal of Drug Issues (Winter 2002).
8. Broadhead RS, van Hulst Y, Heckathorn DD. 1999. The impact of a needle exchange's closure. Public health reports (Washington, DC: 1974) 114(5):439-447. (Pubitemid 29500783)
9. Bula, F. 2002. Drug plan waste of resources, city told; more drug users will come here, U.S. official warns. Vancouver Sun, November 21, 2002.
10. Calzavara LM, Burchell AN, Schlossberg J, Myers T, Escobar M, Wallace E, Major C, Strike C, Millson M. 2003. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 98(9):1257-1265. (Pubitemid 37082819)
11. Case P, Meehan T, Jones TS. 1998. Arrests and incarceration of injection drug users for syringe possession in Massachusetts: Implications for HIV prevention. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 18(Suppl 1):S71-75. (Pubitemid 28304472)
12. Cruz MF, Patra J, Fischer B, Rehm J, Kalousek K. 2007. Public opinion towards supervised injection facilities and heroin-assisted treatment in Ontario, Canada. International Journal of Drug Policy 18:54-61. (Pubitemid 46240798)
13. DeBeck K, Shannon K, Wood E, Li K, Montaner JS, Kerr T. 2007. Income generating activities of people who inject drugs. Drug and Alcohol Dependence 91(1):50-56. (Pubitemid 47385029)
14. Dolan KA, Kimber J, Fry C, McDonald D, Fitzgerald J, Trautmann F. 2000. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 19:337-346.
15. Donnelly N, Snowball L. 2006. Recent trends in property and drug-related crime in Kings Cross. Sydney, Australia: Government of New South Wales.
16. Drucker E. 2006. Insite: Canada's landmark safe injecting program at risk. Harm Reduction Journal 3:24.
17. Dunn J, Laranjeira R. 1999. Cocaine-profiles, drug histories, and patterns of use of patients from Brazil. Substance Use & Misuse 34(11):1527-1548. (Pubitemid 29402431)
18. Freeman K, Jones CG, Weatherburn DJ, Rutter S, Spooner CJ, Donnelly N. 2005. The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime. Drug and Alcohol Review 24(2):173-184. (Pubitemid 41273070)
19. Gandey A. 2003. US slams Canada over Vancouver's new drug injection site. Canadian Medical Association Journal 169(10):1063.
20. Hedrich D. 2004. European report on drug consumption rooms. Luxembourg: European Monitoring Centre for Drugs and Drug Addiction.
21. Kerr T, Fairbairn N, Tyndall MW, Marsh D, Li K, Montaner J, Wood E. 2007. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug and Alcohol Dependence 87(1):39-45. (Pubitemid 46074383)
22. Kerr T, Tyndall M, Li K, Montaner J, Wood E. 2005. Safer injection facility use and syringe sharing in injection drug users. Lancet 366(9482):316-318. (Pubitemid 41019422)
23. Kimber J, Dolan KA, van Beek I, Hedrich D. 2003. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 22:227-233. (Pubitemid 36814874)
24. Lee JH, Herzog TA, Meade CD, Webb MS, Brandon TH. 2007. The use of GEE for analyzing longitudinal binomial data: A primer using data from a tobacco intervention. Addictive behaviors 32(1):187-193. (Pubitemid 44708494)
25. Lines R, Jü rgens R, Betteridge G, Stǒver H, Laticevschi D, Nelles J. 2006. Prison needle exchange: Lessons from a comprehensive review of internvational evidence and experience. Montreal, Canada: HIV/AIDS Legal Network.
26. Macalino GE, Vlahov D, Sanford-Colby S, Patel S, Sabin K, Salas C, Rich JD. 2004. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. American Journal of Public Health 94(7):1218-1223. (Pubitemid 38857326)
27. McElrath K, Chitwood DD, Comerford M. 1997. Crime victimization among injection drug users. Journal of Drug Issues 27(4):771-783. (Pubitemid 28011976)
28. Milloy M-JS, Wood E, Small D, Tyndall M, Lai C, Montaner J, Kerr T. (2008). Incarceration experiences in a cohort of active injection drug users. Drug and Alcohol Review, iFirst ahead of press.
29. Mulgrew I. 2006. Just how bad is local violence, property crime? Statistics show incidents are actually down from previous decade. Vancouver Sun, January 3, 2006.
30. Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. 2005. Heroin overdose among young injection drug users in San Francisco. Drug and Alcohol Dependence 80(3):297-302. (Pubitemid 41660850)
31. Press TC. 2003. Fewer addicts shooting up in the streets since injection site opened: Police. Nanaimo Daily News, November 18, 2003.
32. Rotily M, Weilandt C, Bird SM, Käll K, Van Haastrecht HJ, Iandolo E, Rousseau S. 2001. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. European Journal of Public Health 11(3):243-250. (Pubitemid 32912154)
33. Salmon A. 2006. Sydney Medically Supervised Injecting Centre: Interim Evaluation Report #2: Evaluation of community attitudes towards the Sydney MSIC. Sydney, Australia: National Centre in HIV epidemiology and clinical research.
34. Shah NG, Galai N, Celentano DD, Vlahov D, Strathdee SA. 2006. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988-2000. Drug and Alcohol Dependence 83(2):147-156. (Pubitemid 44208952)
35. Small W, Kain S, Laliberté N, Schechter MT, O'Shaughnessy MV, Spittal PM. 2005. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Substance Use & Misuse 40(6):831-843. (Pubitemid 40807525)
36. Small W, Wood E, Jü rgens R, Kerr T. 2005. Injection drug use, HIV/AIDS and incarceration: Evidence from the Vancouver Injection Drug Users Study. HIV/AIDS policy & law review/Canadian HIV/AIDS Legal Network 10(3):1, 5-10.
37. Spittal PM, Hogg RS, Li K, Craib KJ, Recsky M, Johnston C, Montaner JS, Schechter MT, Wood E. 2006. Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care 18(2):101-108. (Pubitemid 41780168)
38. Strang J, Gossop M, Heuston J, Green J, Whiteley C, Maden A. 2006. Persistence of drug use during imprisonment: Relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison. Addiction 101(8):1125-1132. (Pubitemid 44025312)
39. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, Schechter MT, O'Shaughnessy MV. 1997. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 11(8):F59-65. (Pubitemid 27259515)
40. Sullivan S. 2006. Project Civil City. Vancouver, Canada: City of Vancouver.
41. Tyndall MW, Craib KJ, Currie S, Li K, O'Shaughnessy MV, Schechter MT. 2001. Impact of HIV infection on mortality in a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndrome 28(4):351-357. (Pubitemid 33101288)
42. Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E. 2006. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug and Alcohol Dependence 83(3):193-198.
43. van Beek I. 2006. The Sydney Medically Supervised Injecting Centre: The First Five Years. Syndey, Australia: Sydney Medically Supervised Injecting Centre.
44. Wall R, Rehm J, Fischer B, Brands B, Gliksman L, Stewart J, Medved W, Blake J. 2000. Social costs of untreated opioid dependence. Journal of Urban Health 77(4):688-722. (Pubitemid 32059236)
45. Weild AR, Gill ON, Bennett D, Livingstone SJ, Parry JV, Curran L. 2000. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: A national survey. Communicable Disease and Public Health 3(2):121-126.
46. Wente M. 2002. This quick fix won't work. The Globe and Mail, November 19, 2002.
47. Wood E, Kerr T, Montaner JS, Strathdee SA, Wodak A, Hankins CA, Schechter MT, Tyndall MW. 2004. Rationale for evaluating North America's first medically supervised safer-injecting facility. The Lancet Infectious Diseases 4(5):301-306. (Pubitemid 38561228)
48. Wood E, Kerr T, Small W, Jones J, Schechter MT, Tyndall MW. 2003. The impact of a police presence on access to needle exchange programs. Journal of Acquired Immune Deficiency Syndrome 34(1):116-118. (Pubitemid 37100123)
49. Wood E, Kerr T, Small W, Li K, Marsh DC, Montaner JS, Tyndall MW. 2004. Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users. Canadian Medical Association Journal 171(7):731-734. (Pubitemid 39319089)
50. Wood E, Kerr TH, Lloyd-Smith E, Buchner C, Marsh DC, Montaner JS, Tyndall MW. 2004. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduction Journal 1(1):9.
51. Wood E, Tyndall MW, Montaner JS, Kerr T. 2006. Summary of findings from the evaluation of a pilot medically supervised safer injecting facility. Canadian Medical Association Journal 175(11):1399-1404. (Pubitemid 44876560)